Multicell Technologies, Inc. (PN) Stock Price - MCET

Best deals to access real time data!
Real-Time Alerts for Volume Breakouts, Highs and Lows for OTC Markets and OTCBB
Monthly Subscription
for only
$56.09
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
SMALL CAP PRO
Monthly Subscription
for only
$49.05
VAT not included
Company Name Stock Ticker Symbol Market Type ISIN
Multicell Technologies, Inc. (PN) MCET Other OTC Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  +0 +0% 0.0001 0.0001 0.0001 0.0001 0.0001 09:30:01
Bid Price Ask Price Spread Spread % News
0.0001 0.0001 0 0.00% - -
Stock Trades Traded Volume Average Volume 52 Week Range
1 1,000,000 1.6M 0.0000 - 0.0002
Last Trade Time Type Quantity Stock Price Currency
10:16:26 1,000,000 $0.00 USD

Multicell Technologies, Inc. (PN) Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 500.09k 5B $ -380.07k - -1.32 600k
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Multicell Technologies, Inc. (PN) News

Date Time Source News Article
2/14/201815:29Edgar (US Regulatory)Statement of Ownership (sc 13g)

Latest MCET Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical MCET Price Data

Period † Open High Low VWAP Min Vol Max Vol Avg. Daily Vol [m] Change %
1 Week00.000100.000001000k0--
1 Month00.000100.000001000k0--
3 Months00.000100.000001000k0--
6 Months00.000100.000001000k0--
1 Year00.000100.000001000k0--
3 Years00.000100.000001000k0--
5 Years00.000100.000001000k0--

Multicell Technologies, Inc. (PN) Description

MultiCell Technologies, Inc. is a clinical-stage biopharmaceutical company developing novel therapeutics and discovery tools that address unmet medical needs for the treatment of neurological disorders, hepatic disease, fatigue of MS and cancer. The majority owned Xenogenics subsidiary is developing a drug-eluting cardiac stent.
Your Recent History
USOTC
MCET
Multicell ..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20181218 11:35:51